Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products.
Title: | Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products. |
---|---|
Authors: | Guglielmi, R., Lai, Z., Raba, K., van Dalum, G., Wu, J., Behrens, B., Bhagat, A. A. S., Knoefel, W. T., Neves, R. P. L., Stoecklein, N. H. |
Source: | Scientific Reports; 11/20/2020, Vol. 10 Issue 1, p1-9, 9p |
Subject Terms: | LEUKAPHERESIS, LEUKOCYTES, BIOCHIPS, BUFFY coat, MICROFLUIDIC devices |
Abstract: | Diagnostic leukapheresis (DLA) enables to sample larger blood volumes and increases the detection of circulating tumor cells (CTC) significantly. Nevertheless, the high excess of white blood cells (WBC) of DLA products remains a major challenge for further downstream CTC enrichment and detection. To address this problem, we tested the performance of two label-free CTC technologies for processing DLA products. For the testing purposes, we established ficollized buffy coats (BC) with a WBC composition similar to patient-derived DLA products. The mimicking-DLA samples (with up to 400 × 106 WBCs) were spiked with three different tumor cell lines and processed with two versions of a spiral microfluidic chip for label-free CTC enrichment: the commercially available ClearCell FR1 biochip and a customized DLA biochip based on a similar enrichment principle, but designed for higher throughput of cells. While the samples processed with FR1 chip displayed with increasing cell load significantly higher WBC backgrounds and decreasing cell recovery, the recovery rates of the customized DLA chip were stable, even if challenged with up to 400 × 106 WBCs (corresponding to around 120 mL peripheral blood or 10% of a DLA product). These results indicate that the further up-scalable DLA biochip has potential to process complete DLA products from 2.5 L of peripheral blood in an affordable way to enable high-volume CTC-based liquid biopsies. [ABSTRACT FROM AUTHOR] |
Copyright of Scientific Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
Database: | Complementary Index |
Full text is not displayed to guests. | Login for full access. |
FullText | Links: – Type: pdflink Text: Availability: 1 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edb&genre=article&issn=20452322&ISBN=&volume=10&issue=1&date=20201120&spage=1&pages=1-9&title=Scientific Reports&atitle=Technical%20validation%20of%20a%20new%20microfluidic%20device%20for%20enrichment%20of%20CTCs%20from%20large%20volumes%20of%20blood%20by%20using%20buffy%20coats%20to%20mimic%20diagnostic%20leukapheresis%20products.&aulast=Guglielmi%2C%20R.&id=DOI:10.1038/s41598-020-77227-3 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edb DbLabel: Complementary Index An: 147136748 RelevancyScore: 915 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 915.370544433594 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Guglielmi%2C+R%2E%22">Guglielmi, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Lai%2C+Z%2E%22">Lai, Z.</searchLink><br /><searchLink fieldCode="AR" term="%22Raba%2C+K%2E%22">Raba, K.</searchLink><br /><searchLink fieldCode="AR" term="%22van+Dalum%2C+G%2E%22">van Dalum, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Wu%2C+J%2E%22">Wu, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Behrens%2C+B%2E%22">Behrens, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Bhagat%2C+A%2E+A%2E+S%2E%22">Bhagat, A. A. S.</searchLink><br /><searchLink fieldCode="AR" term="%22Knoefel%2C+W%2E+T%2E%22">Knoefel, W. T.</searchLink><br /><searchLink fieldCode="AR" term="%22Neves%2C+R%2E+P%2E+L%2E%22">Neves, R. P. L.</searchLink><br /><searchLink fieldCode="AR" term="%22Stoecklein%2C+N%2E+H%2E%22">Stoecklein, N. H.</searchLink> – Name: TitleSource Label: Source Group: Src Data: Scientific Reports; 11/20/2020, Vol. 10 Issue 1, p1-9, 9p – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22LEUKAPHERESIS%22">LEUKAPHERESIS</searchLink><br /><searchLink fieldCode="DE" term="%22LEUKOCYTES%22">LEUKOCYTES</searchLink><br /><searchLink fieldCode="DE" term="%22BIOCHIPS%22">BIOCHIPS</searchLink><br /><searchLink fieldCode="DE" term="%22BUFFY+coat%22">BUFFY coat</searchLink><br /><searchLink fieldCode="DE" term="%22MICROFLUIDIC+devices%22">MICROFLUIDIC devices</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Diagnostic leukapheresis (DLA) enables to sample larger blood volumes and increases the detection of circulating tumor cells (CTC) significantly. Nevertheless, the high excess of white blood cells (WBC) of DLA products remains a major challenge for further downstream CTC enrichment and detection. To address this problem, we tested the performance of two label-free CTC technologies for processing DLA products. For the testing purposes, we established ficollized buffy coats (BC) with a WBC composition similar to patient-derived DLA products. The mimicking-DLA samples (with up to 400 × 10<superscript>6</superscript> WBCs) were spiked with three different tumor cell lines and processed with two versions of a spiral microfluidic chip for label-free CTC enrichment: the commercially available ClearCell FR1 biochip and a customized DLA biochip based on a similar enrichment principle, but designed for higher throughput of cells. While the samples processed with FR1 chip displayed with increasing cell load significantly higher WBC backgrounds and decreasing cell recovery, the recovery rates of the customized DLA chip were stable, even if challenged with up to 400 × 10<superscript>6</superscript> WBCs (corresponding to around 120 mL peripheral blood or 10% of a DLA product). These results indicate that the further up-scalable DLA biochip has potential to process complete DLA products from 2.5 L of peripheral blood in an affordable way to enable high-volume CTC-based liquid biopsies. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Group: Ab Data: <i>Copyright of Scientific Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=147136748 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-020-77227-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 1 Subjects: – SubjectFull: LEUKAPHERESIS Type: general – SubjectFull: LEUKOCYTES Type: general – SubjectFull: BIOCHIPS Type: general – SubjectFull: BUFFY coat Type: general – SubjectFull: MICROFLUIDIC devices Type: general Titles: – TitleFull: Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guglielmi, R. – PersonEntity: Name: NameFull: Lai, Z. – PersonEntity: Name: NameFull: Raba, K. – PersonEntity: Name: NameFull: van Dalum, G. – PersonEntity: Name: NameFull: Wu, J. – PersonEntity: Name: NameFull: Behrens, B. – PersonEntity: Name: NameFull: Bhagat, A. A. S. – PersonEntity: Name: NameFull: Knoefel, W. T. – PersonEntity: Name: NameFull: Neves, R. P. L. – PersonEntity: Name: NameFull: Stoecklein, N. H. IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 11 Text: 11/20/2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 20452322 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: Scientific Reports Type: main |
ResultId | 1 |